• A focus on innovation

    Bringing first in class products to the underserved dermatology market

  • Building a franchise in chronic pruritus

  • Low Systemic Exposure platform underpins our growing pipeline

  • Experienced Management Team and Board

Sienna Biopharmaceuticals Acquires Creabilis plc  Read more >>
Creabilis completes EU FP7 project and selects two novel drug candidates for further development in atopic dermatitis and psoriasis  Read more >>
United Kingdom
6 Denne Hill Business Centre
Womenswold
Canterbury, CT4 6HD
Italy
Creabilis Therapeutics Srl
Via Ribes, 5
10010 Colleretto Giacosa (TO)
USA
Sienna Biopharmaceuticals, Inc.
30699 Russell Ranch Road
Suite 140
Westlake Village, CA 91362

About Creabilis

  1. Company Profile

Therapeutic Focus

  1. Dermatology
  2. Chronic Pruritus
  3. Low Systemic Exposure

Products

  1. Pipeline
  2. CT327
  3. CT340
  4. Other Pipeline Products

Investor Relations

  1. Overview

News & Events

  1. Press Releases
  2. Events

Contact us

  1. Location
  • A focus on innovation

    Bringing first in class products to the underserved dermatology market

  • Building a franchise in chronic pruritus

  • Low Systemic Exposure platform underpins our growing pipeline

  • Experienced Management Team and Board

Sienna Biopharmaceuticals Acquires Creabilis plc  Read more >>
Creabilis completes EU FP7 project and selects two novel drug candidates for further development in atopic dermatitis and psoriasis  Read more >>